Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Yun Ju Cho"

Keywords

Publication year

"Yun Ju Cho"

Original Article

Autoimmune liver disease

Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score
Ho Eun Jung, Jae Young Jang, Soung Won Jeong, Jin Nyoung Kim, Hee Yoon Jang, Yun Ju Cho, Sung Ae Woo, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim
Korean J Hepatol 2012;18(4):375-382.
Published online December 21, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.4.375
Background/Aims

Primary biliary cirrhosis (PBC) is a slowly progressing autoimmune disease of the liver that is characterized by portal inflammation and immune-mediated destruction of the intrahepatic bile ducts. Serum total bilirubin is one of the various prognostic factors that have been proposed. A recent study found that PBC with accompanying autoimmune hepatitis (AIH) carries a negative prognosis. This study examined the clinical characteristics of PBC and analyzed the factors that affect its prognosis.

Methods

Patients diagnosed with PBC between January 1998 and December 2010 based on clinical and histopathological findings were compiled and analyzed retrospectively.

Results

Among 27 patients, 24 (1 male and 23 females, ages 50.0±9.3 years) were followed up. The follow-up period was 8.6±0.9 years. Of the 24 patients, 9 patients progressed to liver cirrhosis (LC). Comparison between patients who did and did not progress to LC revealed statistically significant differences in the patients' serum total bilirubin (2.7±1.8 vs. 0.8±0.4, P=0.012), the Mayo risk score (5.1±0.7 vs. 3.9±0.6, P=0.001), the revised IAHG (International Autoimmune Hepatitis Group) score (9.2±2.3 vs. 5.4±3.0, P=0.004) and frequency of AIH overlap (5/9 [55.6%] vs. 0/15 [0%], P=0.001) at the time of diagnosis.

Conclusions

We propose that serum total bilirubin, the Mayo risk score, and the revised IAHG score at the time of diagnosis are helpful for predicting PBC prognosis. In particular, since all of the patients with accompanying AIH progressed to LC, the presence of overlap syndrome at the time of diagnosis is helpful for predicting PBC prognosis and providing an adequate treatment.

Citations

Citations to this article as recorded by  Crossref logo
  • Impact of Type 2 Diabetes Mellitus on Liver Fibrosis and Hepatic Steatosis in Patients with Primary Biliary Cholangitis: A Longitudinal Study
    Elizabeth E. Williams, Craig Lammert, Raj Vuppalanchi
    Digestive Diseases and Sciences.2026;[Epub]     CrossRef
  • Network meta-analysis: relative clinical efficacy and safety of elafibranor versus seladelpar as second-line treatment for patients with primary biliary cholangitis
    David Jones, Emily Combe, Harun Knight, Vicki Laskier-Owens, Shijie Ren, Tom Wright, Elaine A Böing, Alex Pashley
    Journal of Comparative Effectiveness Research.2026;[Epub]     CrossRef
  • Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective
    Sylvia Drazilova, Tomas Koky, Marian Macej, Martin Janicko, Dagmar Simkova, Ariunzaya Tsedendamba, Slavomira Komarova, Peter Jarcuska
    Gastroenterology Insights.2024; 15(2): 419.     CrossRef
  • Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis
    Albert Parés, Mitchell Shiffman, Victor Vargas, Pietro Invernizzi, Elizabeth S. Malecha, Alexander Liberman, Leigh MacConell, Gideon Hirschfield
    Liver International.2020; 40(5): 1121.     CrossRef
  • Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients
    Steven Shinn-Forng Peng, Yung-Ming Jeng, Wen-Ming Hsu, Justin Cheng-Ta Yang, Ming-Chih Ho
    European Radiology.2015; 25(10): 2992.     CrossRef
  • Overlap syndromes of autoimmune hepatitis: diagnosis and treatment
    O. Aguilar-Nájera, J.A. Velasco-Zamora, A. Torre
    Revista de Gastroenterología de México (English Edition).2015; 80(2): 150.     CrossRef
  • Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes
    Yoonsang Park, Yuri Cho, Eun Ju Cho, Yoon Jun Kim
    Clinical and Molecular Hepatology.2015; 21(2): 150.     CrossRef
  • Diagnóstico y tratamiento de los síndromes de sobreposición de hepatitis autoinmune
    O. Aguilar-Nájera, J.A. Velasco-Zamora, A. Torre
    Revista de Gastroenterología de México.2015; 80(2): 150.     CrossRef
  • Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis
    Vasiliy Ivanovich Reshetnyak
    World Journal of Gastroenterology.2015; 21(25): 7683.     CrossRef
  • Primary Biliary Cirrhosis and Primary Sjögren's Syndrome: Insights for the Stomatologist
    Liliane Lins, Raymundo Paraná, Silvia Regina Almeida Reis, Antônio Fernando Pereira Falcão
    Case Reports in Gastroenterology.2014; 8(2): 251.     CrossRef
  • 16,338 View
  • 70 Download
  • Crossref